CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Clinical Data LLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Clinical Data LLC
1 Gateway Ctr Ste 702
Phone: (617) 527-9933p:617 527-9933 NEWTON, MA  02458-2831  United States Ticker: CLDACLDA
This company ceased filing statements with the SEC on 4/25/2011.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Clinical Data LLC is a United States-based company. The Company is focused on development and commercialization of novel therapeutics, with two compounds in the areas of central nervous system and cardiovascular disorders. The Company's late-stage drug candidate is vilazodone, a dual-acting selective and potent serotonin reuptake inhibitor and serotonin receptor 1A (5-HT1A) partial agonist for the treatment of Major Depressive Disorder (MDD) for which a New Drug Application (NDA) was filed with the U.S. Food and Drug Administration (FDA).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20103/31/2010YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Director HowardSolomon 86 4/13/2011 4/12/2011
Chief Executive Officer Andrew J.Fromkin 55 4/13/2011 5/12/2006
Chief Financial Officer, Executive Vice President C. EvanBallantyne 56 1/1/2009 8/7/2006
7 additional Officers and Directors records available in full report.

Business Names
Business Name
API Acquisition Sub, Inc.
Avalon Pharmaceuticals, Inc.
CLDA
PGxHealth Holding, Inc.
PGxHealth, LLC

General Information
Number of Employees: 160 (As of 3/31/2010)
Outstanding Shares: 29,959,000 (As of 12/31/2010)
Shareholders: 467
Stock Exchange: NASD
Federal Tax Id: 042573920
Fax Number: (302) 636-5454
Email Address: info@novitronintl.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023